HDL as a contrast agent for medical imaging

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Cardiovascular Research

Background:

• Atherosclerosis diagnosis and monitoring require advanced imaging techniques.
• High-density lipoprotein (HDL) interacts with atherosclerotic plaque.
• HDL's properties make it suitable for delivering imaging agents.

Purpose of the Study:

• To review the use of gadolinium-modified HDL as an MRI contrast agent for atherosclerosis.
• To explore HDL modifications for other imaging modalities like fluorescence and CT.
• To assess HDL's specificity for macrophages in atherosclerotic lesions.

Main Methods:

• Modification of HDL with gadolinium for MRI contrast enhancement.
• Functionalization of HDL with fluorophores and nanocrystals for optical and CT imaging.
• Evaluation of macrophage specificity of modified HDL in preclinical atherosclerosis models.

Main Results:

• Modified HDL effectively acts as an MRI contrast agent for atherosclerosis.
• HDL-based agents are also suitable for fluorescent imaging and computed tomography.
• Modified HDL demonstrates macrophage specificity, enabling noninvasive assessment of macrophage density.

Conclusions:

• Modified HDL is a valuable tool for probing preclinical atherosclerosis.
• Future applications may extend to other diseases and physiological processes.
• HDL-based contrast agents hold potential for both preclinical research and clinical diagnostics.